Clinical Trial Update: Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intratumoral MMR vaccine injection for borderline resectable/unresectable pancreatic cancer (Phase 1/2); the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• MMR vaccine (Measles, Mumps, and Rubella vaccine)

Snippet

Sponsor: University of Arkansas | Conditions: Borderline Resectable/Unresectable Pancreatic Cancer, Non Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING